Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

amicus therapeutics

POPULAR ARTICLES

An Investor’s Guide to Clinical Trials

An Investor’s Guide to Clinical Trials

Amicus Therapeutics Announces First Patient Dosed in Phase 3 PROPEL Pivotal Study of AT-GAA in Patients with Pompe Disease

Amicus Therapeutics Announces Regulatory and Clinical Updates for AT-GAA in Pompe Disease

LATEST ARTICLES

pharmaceutical investing

Amicus Therapeutics Announces Approval of Galafold® (Migalastat) for Fabry Disease in Japan

Amicus Therapeutics Announces Full-Year 2017 Financial Results and 2018 Corporate Updates

Amicus Therapeutics Prices Underwritten Offering of Common Stock

Amicus Therapeutics Announces Public Offering of Common Stock

U.S. FDA Files New Drug Application Under Priority Review for Migalastat for Treatment of Fabry Disease

Canadian Drug Expert Committee Grants Positive Recommendation for Reimbursement of Galafold

Amicus Therapeutics Launches Treatment of Fabry Disease in Spain

Biotech Investing

The Case for Investing in Biotech

Latest News

1911 Gold Temporarily Suspends Operations at True North Complex due to Bissett Evacuation Order

Brunswick Exploration Completes Brokered Private Placement for Gross Proceeds of C$3.5 Million

Juggernaut Files for Final Approval of Oversubscribed Financing

Quimbaya Gold Inc. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

Charbone Hydrogen Announces Q1 2025 Financial Results